Taiko Pharmaceutical Company., Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiko Pharmaceutical Company., Limited with three other
pharmaceutical manufacturers in Asia:
Sms Pharmaceuticals Limited
sales of 6.03 billion Indian Rupees [US$90.30 million]
of which 100%
Ttk Healthcare Limited
(5.19 billion Indian Rupees [US$77.67 million]
of which 53%
was Pharmaceuticals), and
Yuyu Pharma Incorporated
based in South Korea
(69.74 billion Korean Won [US$61.72 million]
Taiko Pharmaceutical Company., Limited reported sales of ¥8.33 billion (US$79.86 million)
March of 2016.
decrease of 7.3%
versus 2015, when the company's sales were ¥8.98 billion.
Contributing to the drop in overall sales was the 30.7% decline
in Infection Control, from ¥3.20 billion to ¥2.22 billion.
However, these declines were partially offset by the increase in sales of
Medicine Goods (up 5.7% to ¥6.08 billion)
Other (up 15.6% to ¥23.78 million)